Glassy cell carcinoma of the uterine cervix: a rare entity and literature review

被引：0

作者：

Tenazoa-Villalobos, Jose Richard ^{[1
,2
]}

Yan-Quiroz, Edgar Fermin ^{[2
,3
,4
]}

Ordonez-Chinguel, Augusto ^{[5
,6
]}

Prado-Cucho, Sofia Leonor ^{[5
,6
]}

Miranda-Narro, Adesman Isac ^{[1
,2
,7
]}

Villoslada-Terrones, Vladimir ^{[5
,6
]}

机构：

[1] Oncol Surg Area Victor Lazarte Echegaray Hosp EsSa, Trujillo 13013, Peru

[2] Univ Privada Antenor Orrego, Sch Med, Trujillo 13008, Peru

[3] Oncol Surg Area Virgen Puerta High Complex Hosp Es, La Esperanza 13013, Peru

[4] Univ Cesar Vallejo, Sch Med, Trujillo 13008, Peru

[5] Inst Nacl Enfermedades Neoplas INEN, Lima 15036, Peru

[6] Univ Peruana Cayetano Heredia, Fac Med, Lima 150135, Peru

[7] Natl Univ Trujillo, Fac Med, Trujillo 13008, Peru

来源：

ECANCERMEDICALSCIENCE | 2025年 / 19卷

关键词：

glassy cell carcinoma; cervical cancer; chemotherapy; radiotherapy; radical hysterectomy; ADJUVANT THERAPY; HIGH-RISK; CANCER; CHEMOTHERAPY; RADIATION;

D O I：

10.3332/ecancer.2025.1842

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Glassy cell carcinoma is an extremely rare entity that occurs in 1% to 2% of all cases of cervical cancer, affects young women with greater predisposition, is related to poor prognosis, and distant metastasis. It correlates strongly with the presence of high-risk human papillomavirus (serotypes 16, 18 and 31) and histologically manifests as ground-glass cells, cytosol with vast granular and dense chromatin with large nuclei and protruding nucleoli. We present a 51-year-old woman who was diagnosed with glassy cell carcinoma of the cervix (before the latest edition of the World Health Organisation classification of tumours) in FIGO stage IB1 that was managed with radical hysterectomy and bilateral pelvic lymph node dissection, whose pathological result shows infiltration of the upper third of the vagina, changing the staging to FIGO IIA-1. She received adjuvant concurrent radiotherapy/chemotherapy with a good response, subsequent controls without signs of recurrence and remained currently alive.

引用

页数：8

共 32 条

[1] Bray F, Laversanne M, Sung H, Et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 74, 3, pp. 229-263, (2024)
[2] Siegel RL, Giaquinto AN, Jemal A, Cancer statistics, 2024 CA Cancer J Clin, 74, 1, pp. 12-49, (2024)
[3] Torre LA, Bray F, Siegel RL, Et al., Global cancer statistics, 2012 CA Cancer J Clin, 65, 2, pp. 87-108, (2015)
[4] Boustani J, Achkar S, Bertaut A, Et al., Glassy cell carcinoma of the uterine cervix: 20-year experience from a comprehensive cancer center, Cancer Radiother, 25, 3, pp. 207-212, (2021)
[5] Cannistra SA, Niloff JM, Cancer of the uterine cervix, N Engl J Med, 334, 16, pp. 1030-1038, (1996)
[6] Zolciak-Siwinska A, Jonska-Gmyrek J, Glassy cell carcinoma of the cervix: a literature review, Eur J Obstet Gynecol Reprod Biol, 179, pp. 232-235, (2014)
[7] Littman P, Clement PB, Henriksen B, Et al., Glassy cell carcinoma of the cervix, Cancer, 37, 5, pp. 2238-2246, (1976)
[8] Cherry CP, Glucksmann A, Incidence, histology, and response to radiation of mixed carcinomas (adenoacanthomas) of the uterine cervix, Cancer, 9, 5, pp. 971-979, (1956)
[9] Piura B, Rabinovich A, Meirovitz M, Et al., Glassy cell carcinoma of the uterine cervix, J Surg Oncol, 72, 4, pp. 206-210, (1999)
[10] Kato N, Katayama Y, Kaimori M, Et al., Glassy cell carcinoma of the uterine cervix: histochemical, immunohistochemical, and molecular genetic observations, Int J Gynecol Pathol, 21, 2, pp. 134-140, (2002)

← 1 2 3 4 →